Application 062512
- Type
- ANDA
- Sponsor
- WOCKHARDT BIO AG
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NYSTATIN | NYSTATIN | SUSPENSION;ORAL | 100,000 UNITS/ML | No | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A062512-001 | NYSTATIN | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 1984-10-29 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A062512-001 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A062512-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 1984-10-29 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A062512-001 | AA | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nystatin Oral Suspension | NYSTATIN | Xttrium Laboratories, Inc. | 4a670371-d373-1ba6-e063-6394a90a13b6 | 2026-02-06 | Adverse reactions | 062512 ANDA062512 |
| Nystatin | NYSTATIN | A-S Medication Solutions | e069d495-7f1a-4970-8f4d-aa93d124b3fc | 2023-02-04 | Adverse reactions | 062512 ANDA062512 50090-1740 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0121-4785 | Nystatin | Nystatin | Pharmaceutical Associates, Inc. | ANDA | Current |
| 17856-0037 | Nystatin | Nystatin | ATLANTIC BIOLOGICALS CORP. | ANDA | Current |
| 17856-0538 | Nystatin | Nystatin | ATLANTIC BIOLOGICALS CORP. | ANDA | Current |
| 42254-067 | Nystatin | Nystatin | Rebel Distributors Corp | ANDA | Current |
| 50090-1740 | Nystatin | nystatin | A-S Medication Solutions | ANDA | Current |
| 55154-1578 | Nystatin | Nystatin | Cardinal Health 107, LLC | ANDA | Current |
| 55154-1578 | Nystatin | Nystatin | Cardinal Health | ANDA | Current |
| 55154-1578 | Nystatin | Nystatin | Cardinal Health | ANDA | Current |
| 55154-1578 | Nystatin | Nystatin | Cardinal Health | ANDA | Current |
| 60432-537 | Nystatin | nystatin | Morton Grove Pharmaceuticals, Inc. | ANDA | Current |
| 63629-2598 | Nystatin | Nystatin | Bryant Ranch Prepack | ANDA | Current |
| 63739-634 | Nystatin | Nystatin | McKesson Corporation | ANDA | Current |
| 63739-634 | Nystatin | nystatin | McKesson Corporation dba SKY Packaging | ANDA | Current |
| 68094-599 | Nystatin | Nystatin | Precision Dose, Inc. | ANDA | Current |
| 68094-599 | Nystatin | Nystatin | Precision Dose, Inc. | ANDA | Current |
| 68094-599 | Nystatin | Nystatin | Precision Dose, Inc. | ANDA | Current |
| 68094-599 | Nystatin | Nystatin | Precision Dose, Inc. | ANDA | Current |
| 68788-6792 | Nystatin | Nystatin | Preferred Pharmaceuticals, Inc. | ANDA | Current |
| 68788-6792 | Nystatin | Nystatin | Preferred Pharmaceuticals, Inc. | ANDA | Current |
| 68788-6792 | Nystatin | Nystatin | Preferred Pharmaceuticals, Inc. | ANDA | Current |
| 68788-6792 | Nystatin | Nystatin | Preferred Pharmaceuticals, Inc. | ANDA | Current |